The US Food and Drug Administration has issued an important safety warning regarding popular weight loss drugs including Ozempic, Wegovy, and Mounjaro. An extensive review of 126 clinical trials involving over 1.34 lakh patients revealed a potential link between these GLP 1 medications and NAION, a rare eye condition capable of causing sudden vision changes. Officials recommend updated labels and immediate medical attention for any symptoms.
